Cengild Medical Berhad (KLSE:0243) — Stock Price
Cengild Medical Berhad (KLSE:0243) is currently trading at RM0.20 MYR, up 2.63% today. Over the past 52 weeks, shares have ranged between RM0.19 and RM0.24. This page tracks Cengild Medical Berhad's live share price on the KLSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see how efficiently does Cengild Medical Berhad generate cash.
Cengild Medical Berhad (0243) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Cengild Medical Berhad's daily closing share price and trading volume on the KLSE exchange over the past year, giving a clear view of recent price momentum and liquidity.
Cengild Medical Berhad Income Statement — Revenue, Profit & Earnings by Year
Cengild Medical Berhad's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | RM73.21 Million | RM80.00 Million | RM66.82 Million | RM70.28 Million | RM64.44 Million |
| Cost of Revenue | RM38.61 Million | RM43.12 Million | RM35.75 Million | RM39.55 Million | RM38.39 Million |
| Gross Profit | RM34.59 Million | RM36.87 Million | RM31.07 Million | RM30.73 Million | RM26.05 Million |
| Research & Development | — | — | — | — | — |
| SG&A | RM23.44 Million | RM22.05 Million | RM17.86 Million | RM16.24 Million | RM14.48 Million |
| Total Operating Expenses | RM59.09 Million | RM60.96 Million | RM53.61 Million | RM55.79 Million | RM51.48 Million |
| Operating Income | RM14.12 Million | RM19.03 Million | RM13.21 Million | RM14.49 Million | RM12.97 Million |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | — | RM18.11 Million | RM11.57 Million |
| Interest Expense | RM189.00K | RM386.00K | RM601.99K | RM734.32K | RM846.36K |
| Income Before Tax | RM14.04 Million | RM18.01 Million | RM16.73 Million | RM17.37 Million | RM12.11 Million |
| Income Tax Expense | — | — | — | RM4.09 Million | RM2.72 Million |
| Net Income | RM11.44 Million | RM11.06 Million | RM11.08 Million | RM13.29 Million | RM9.39 Million |
Cengild Medical Berhad Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Cengild Medical Berhad's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | RM224.00 Million | RM180.49 Million | RM132.44 Million | RM131.73 Million | RM119.54 Million |
| Total Current Assets | RM62.66 Million | RM98.44 Million | RM99.39 Million | RM106.16 Million | RM93.74 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | RM40.24 Million | RM72.64 Million | RM87.62 Million | RM97.55 Million | RM80.56 Million |
| Net Receivables | RM7.90 Million | RM8.48 Million | RM6.17 Million | RM4.73 Million | RM4.78 Million |
| Inventory | RM2.62 Million | RM2.05 Million | RM1.72 Million | RM1.38 Million | RM1.15 Million |
| Property, Plant & Equipment | — | — | — | RM23.89 Million | RM24.35 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | RM103.97 Million | RM66.03 Million | RM21.15 Million | RM25.62 Million | RM26.59 Million |
| Total Current Liabilities | RM19.69 Million | RM20.05 Million | RM14.77 Million | RM11.39 Million | RM11.66 Million |
| Long-term Debt | RM83.50 Million | RM42.82 Million | RM0.00 | — | — |
| Net Debt | RM76.10 Million | RM31.02 Million | — | — | — |
| Total Stockholder Equity | RM120.02 Million | RM114.46 Million | RM111.30 Million | RM106.11 Million | RM92.95 Million |
| Retained Earnings | RM30.13 Million | RM24.52 Million | RM21.54 Million | RM16.63 Million | RM9.40 Million |
Cengild Medical Berhad Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Cengild Medical Berhad generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | RM13.10 Million | RM16.08 Million | RM12.94 Million | RM13.76 Million | RM14.05 Million |
| Capital Expenditures | RM81.35 Million | RM37.26 Million | RM15.73 Million | RM2.13 Million | RM427.67K |
| Free Cash Flow | RM-68.25 Million | RM-21.18 Million | RM-2.80 Million | RM11.78 Million | RM13.63 Million |
| Investing Cash Flow | — | — | — | RM50.65 Million | RM-47.93 Million |
| Financing Cash Flow | — | — | — | RM-2.50 Million | RM66.03 Million |
| Dividends Paid | RM5.83 Million | RM8.08 Million | RM6.16 Million | RM6.06 Million | RM6.06 Million |
| Stock-Based Compensation | RM-41.00K | RM181.00K | RM261.72K | RM392.85K | RM87.70K |
| Depreciation | RM5.59 Million | RM6.50 Million | RM4.01 Million | RM3.17 Million | RM4.41 Million |
| Change in Cash | RM16.00K | RM10.32 Million | RM-74.94 Million | RM61.92 Million | RM32.16 Million |
Cengild Medical Berhad Earnings History — EPS Actual vs. Analyst Estimates
Track Cengild Medical Berhad's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 30, 2026 | 0.01 | — | — |
| Mar 31, 2026 | 0.00 | — | — |
| Dec 31, 2025 | 0.00 | — | — |
| Sep 30, 2025 | 0.00 | — | — |
| Jun 30, 2025 | 0.00 | — | — |
| May 29, 2025 | 0.00 | — | — |
| Jan 24, 2025 | 0.00 | — | — |
| Sep 30, 2024 | 0.00 | — | — |